
Muse bio appoints Kevin Ness new company CEO
BOULDER -- Muse bio , a privately-held company leading the development of next-generation genome engineering technologies, announced Dr.Kevin Ness has been appointed CEO and a member of the... Read More
Friday December 9, 2016

CU-led team will use $9.2M DOE grant to modify E.coli bacteria into biofuels
BOULDER - A team led by the University of Colorado Boulder has been awarded $9.2 million over the next five years from the U.S. Department of Energy to research modifying E.coli to... Read More
Tuesday December 11, 2012